Publications by authors named "Aurelien Zarca"

Claim this Profile
P
Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3.
Aurelien M Zarca, Ilze Adlere, Cristina P Viciano, Marta Arimont-Segura, Max Meyrath

Mol Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization.
Aurélien Zarca, Claudia Perez, Jelle van den Bor, Jan Paul Bebelman, Joyce Heuninck

Cells· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4.
Cristina Perpiñá-Viciano, Ali Işbilir, Aurélien Zarca, Birgit Caspar, Laura E Kilpatrick

Mol Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status.
Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J Hill

Mol Pharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3.
Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W M De Groof, Bas van der Woning

Mol Pharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions.
Vladimir Bobkov, Aurelien M Zarca, Anneleen Van Hout, Marta Arimont, Jordi Doijen

Biochem Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis